Compass Therapeutics, Inc. (CMPX) vs Journey Medical Corporation (DERM)
A side-by-side comparison of Compass Therapeutics, Inc. and Journey Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CMPX
Compass Therapeutics, Inc.
$0.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DERM
Journey Medical Corporation
$6.69HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CMPX vs DERM
growth of $100 · dividends reinvested · last 5yCMPX -72.9% (-23.0%/yr)DERM -29.6% (-6.8%/yr)DERM compounded faster over this window
CMPX DERM
CMPX vs DERM: by the numbers
- •DERM is the larger company ($184M vs $173M market cap).
- •Both run net losses; CMPX's is the smaller (0.00% vs -8.95% net margin).
Metrics side by side
Valuation
| Metric | CMPX | DERM |
|---|---|---|
| P/S ratio | N/A | 2.70 |
| P/B ratio | 1.04 | 5.73 |
| EV / EBITDA | N/A | 145.81 |
Profitability
| Metric | CMPX | DERM |
|---|---|---|
| Gross margin | 0.00% | 62.24% |
| Operating margin | 0.00% | -13.21% |
| Net margin | 0.00% | -8.95% |
| ROE | -44.23% | -19.01% |
| ROIC | -46.59% | -5.22% |
Growth (annualized)
| Metric | CMPX | DERM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.75% |
| Total return CAGR (5Y) | -22.79% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.